USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
14 Dec 2022 | 03:45 PM GMT

Innovative Distribution Strategies for DTx

Anchored by:

Francesca Wuttke
Founder & CEO
NEN HEALTH

Participants:

Francesca Wuttke Founder & CEOnen Health
Francesca Wuttke
Founder & CEOnen Health
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Ivan Jurisic Head of ProductPatients Influence
Ivan Jurisic
Head of ProductPatients Influence
Malin Johansson Vice PresidentNovo Nordisk
Malin Johansson
Vice PresidentNovo Nordisk
Mark Wuttke CEODopavision
Mark Wuttke
CEODopavision
PR
Parisa "Risa" Vatanka, PharmD, CTTS Senior Director Corporate AlliancesAmerican Pharmacists Association
PR
Parisa "Risa" Vatanka, PharmD, CTTS
Senior Director Corporate AlliancesAmerican Pharmacists Association
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC

About this Meeting

Small, intimate and participant-led discussions tackling digital health challenges. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.  

Currently, there is no one-size-fits-all strategy for DTx distribution. Most companies have been using traditional distribution strategies for their products, but adoption remains a challenge and the market is now becoming more competitive. Hence, it is important to innovate the distribution strategies to try to reach more patients and increase both patient and HCPs’ adoption.  

How can DTx companies better dispense their services to end-users? How to implement innovative and efficient distribution strategies? Join this meeting to discuss more about: 

  • When are telehealth platforms a good distribution strategy for DTx solutions? Can they serve as an adoption booster? What are the challenges? 
  • How can DTx companies leverage pharmacies as a distribution channel for OTC DTx? What are the differences between the US and Europe? How to use them to act as a DTx hub? 
  • Telehealth as a distribution channel or as part of the solution? Alongside being distribution channels, how can DTx leverage these channels (e.g. pharmacies, telehealth platforms) to provide an integrated virtual care continuum? 
  • Beyond telehealth platforms and pharmacies, what other distribution channels can help scale DTx solutions? Are PBMs a good option in the US? What is the role of platforms like ORCHA in the UK? 
  • Understanding and meeting the needs of your distributor is essential. How to do that efficiently? 
  • Some companies opt to use multiple distribution strategies to reach different consumer bases. What are the advantages and disadvantages of having multiple distribution methods?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.